Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 77 for soft tissue sarcoma

Edit search filters
  1. Spearhead 1 Study In Subjects With Advanced Synovial Sarcoma Or Myxoid/Round Cell Liposarcoma

    Jacksonville, FL

  2. A Study Of Unesbulin In Participants With Advanced Leiomyosarcoma (LMS)

    Jacksonville, FL

  3. Proton Or Photon RT For Retroperitoneal Sarcomas

    Rochester, MN

  4. A Study To Assess The Safety And Antitumor Activity Of Genetically Engineered T Cells In NY-ESO-1 And/or LAGE-1a Positive Solid Tumors

    Jacksonville, FL, Rochester, MN

  5. (Peak) A Phase 3 Randomized Trial Of CGT9486+Sunitinib Vs. Sunitinib In Subjects With Gastrointestinal Stromal Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Phase 3 Study Of DCC-2618 Vs Placebo In Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies

    Jacksonville, FL, Rochester, MN

  7. Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma

    Rochester, MN

  8. Vinorelbine Tartrate and Cyclophosphamide in Combination with Bevacizumab or Temsirolimus in Treating Patients with Recurrent or Refractory Rhabdomyosarcoma

  9. A Study Of Vaccine Therapy In Treating Patients With Malignant Peripheral Nerve Sheath Tumors That Are Recurrent Or Cannot Be Removed By Surgery

    Rochester, MN

  10. A Study Of DCC-2618 Vs. Sunitinib In Advanced GIST Patients After Treatment With Imatinib

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer